Cibus (CBUS) Interest & Investment Income (2018 - 2021)
Cibus (CBUS) posted Interest & Investment Income of $1000.0 for Q4 2021, down 50.0% sequentially from $2000.0 in Q2 2021, and down 92.31% YoY from $13000.0 in Q4 2020.
Cibus (CBUS) Interest & Investment Income (2018 - 2021) Analysis & Trends
Cibus has reported Interest & Investment Income for 4 years, with the latest figure at $1000.0 in Q4 2021.
- Quarterly Interest & Investment Income fell 92.31% year-over-year to $1000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $17000.0 (down 96.95% YoY) and the FY2021 annual result came in at $17000.0, down 96.95% from the prior year.
- Interest & Investment Income slipped to $1000.0 in Q4 2021 per CBUS's latest filing, from $2000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $577000.0 in Q3 2018 and troughed at -$26000.0 in Q1 2020.
- A 4-year average of $246333.3 and a median of $190000.0 in 2019 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2019 and 2020: Interest & Investment Income surged 224.55% in 2019, then slumped 104.8% in 2020.
- Over 4 years, Interest & Investment Income stood at $532000.0 in 2018, then sank by 64.29% to $190000.0 in 2019, then tumbled by 93.16% to $13000.0 in 2020, then plunged by 92.31% to $1000.0 in 2021.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1000.0, $2000.0, and $14000.0 for Q4 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 28.14 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 10.98 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 5.13 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 115.94 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 111,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 14,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 45,000.00 |
| Jun 30, 2020 | 525,000.00 |
| Mar 31, 2020 | -26,000.00 |
| Dec 31, 2019 | 190,000.00 |
| Sep 30, 2019 | 406,000.00 |
| Jun 30, 2019 | 462,000.00 |
| Mar 31, 2019 | 542,000.00 |
| Dec 31, 2018 | 532,000.00 |
| Sep 30, 2018 | 577,000.00 |
| Jun 30, 2018 | 245,000.00 |
| Mar 31, 2018 | 167,000.00 |